abrdn Life Sciences Investors (HQL) vs Oxford Lane Capital (OXLC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
abrdn Life Sciences Investors (HQL) has outperformed Oxford Lane Capital (OXLC) over the past year, losing 8.5% versus a loss of 62.5%. Over five years, HQL leads with a -22.8% price change compared with -87.4% for OXLC. Oxford Lane Capital offers the higher dividend yield (48.58% vs 12.42%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HQL | OXLC |
|---|---|---|
| Share price | $15.38 | $4.94 |
| Market cap | — | $484.27M |
| 1-day change | -3.81% | 0.00% |
| YTD return | -8.34% | -66.26% |
| 1-year return | -8.51% | -62.46% |
| 5-year return | -22.83% | -87.37% |
| P/E ratio (TTM) | 2.32 | — |
| Forward P/E | — | 1.41 |
| EPS (TTM) | $6.64 | $-5.62 |
| Dividend yield | 12.42% | 48.58% |
| Annual dividend | $1.91 | $2.40 |
| 52-week high | $22.67 | $15.39 |
| 52-week low | $15.35 | $4.62 |
| Distance from 52-week high | -32.16% | -67.90% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +153.04% |
| Average volume | 129.21K | 1.54M |
| Shares outstanding | — | 98.03M |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HQL has outperformed OXLC by 54.0 percentage points over the past year.
- Oxford Lane Capital offers a meaningfully higher dividend yield (48.58% vs 12.42%).
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
About Oxford Lane Capital
OXLC stock →Oxford Lane Capital Corp. is a close ended fund launched and managed by Oxford Lane Management LLC.
Finance · Investment Managers
HQL vs OXLC FAQ
Which stock has performed better over the past year, HQL or OXLC?
HQL returned -8.51% over the past 12 months, compared with -62.46% for OXLC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, abrdn Life Sciences Investors or Oxford Lane Capital?
Oxford Lane Capital has the higher yield at 48.58%, compared with 12.42% for abrdn Life Sciences Investors.
Are abrdn Life Sciences Investors and Oxford Lane Capital in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.